The Past, Present, and Future of Intravenous Platelet Inhibition in the Catheterization Laboratory

Faculty and Program

Srihari Naidu, MD, FSCAI
Moderator

Megha Prasad, MD
A Deep Dive of the CHAMPION Trials

Nadia Sutton, MD, MPH, FSCAI
Real World and On-Going Studies of IV Platelet Inhibition

Peter Monteleone, MD, FSCAI
Case Presentation of Heavy Thrombus Burden

Binita Shah, MD, FSCAI
Panelist

Jay Giri, MD, FSCAI
Panelist

Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Chiesi.

Learning Objectives

Upon completion of this activity, participants will be able to:

Review trial data supporting the use of IV P2Y12 Inhibitor therapy
Examine registry data and on-going trials regarding IV P2Y12 inhibitor therapy use in the cath lab
Discuss the application of pharmacotherapy in treating high clot burden

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Summary


Availability:	On-Demand
	Access expires on 07/31/2024


Cost:	FREE


Credit Offered:	1 CME Credit 1 ABIM-MOC Point 1 Participation Credit